Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.


Subscribe or Register

Existing user? Login


Medicines regulation

Parliament approves changes to regulations governing controlled drugs

The UK Parliament has approved a raft of amendments to the Misuse of Drugs Regulations 2001 that will come into force over the next few months.

Among the changes are additional controls on temazepam prescribing, the upgrading of ketamine to a Schedule 2 controlled drug and the extension of prescribing authority for physiotherapists, chiropodists and podiatrists.

The Misuse of Drugs Regulations set out the legal status of substances classified under the Misuse of Drugs Act 1971. Drugs are placed in one of five schedules based on an assessment of their medicinal or therapeutic usefulness and the need for legitimate access.

The latest amendments to the Regulations were approved by Parliament on 26 March 2015 and will be rolled out between June and November 2015.

From 1 June 2015, prescriptions for temazepam will need to meet all requirements for Schedule 2 and 3 controlled drugs; electronic prescribing of drugs in these schedules will be permitted. And midwife supply orders for controlled drugs will need to include the name of the intended recipient.

Also from June 2015, physiotherapists will be allowed to prescribe some controlled drugs for treatment of organic disease or injury, including diazepam, dihydrocodeine, fentanyl, lorazepam, morphine, oxycodone and temazepam; chiropodists/podiatrists will be allowed to prescribe diazepam, dihydrocodeine, lorazepam and temazepam.

From 30 November 2015, tighter restrictions will be applied to ketamine, which is being upgraded from a Schedule 4 to a Schedule 2 substance. There will be exceptions to allow for the continued use of ketamine by healthcare professionals. 

  • This article was updated on 29 April 2015 to correct the spelling of temazepam

Citation: The Pharmaceutical Journal DOI: 10.1211/PJ.2015.20068329

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

  • Drugs of Abuse

    Drugs of Abuse

    A concise, easy-to-read guide for healthcare professionals who encounter drug abuse.

    £38.00Buy now
  • Pharmaceutical Toxicology

    Pharmaceutical Toxicology

    Explains the methodology and requirements of pre-clinical safety assessments of new medicines. Includes registration requirements and pharmacovigilance.

    £40.00Buy now
  • Drugs and the Liver

    Drugs and the Liver

    Drugs and the Liver assists practitioners in making pragmatic choices for their patients. It enables you to assess liver function and covers the principles of drug use in liver disease.

    £38.00Buy now
  • Clarke's Analysis of Drugs and Poisons

    Clarke's Analysis of Drugs and Poisons

    Clarke's Analysis of Drugs and Poisons is the definitive reference source of analytical data for drugs and poisons.

    £535.00Buy now
  • Injectable Drugs Guide

    Injectable Drugs Guide

    A user friendly, single point of reference for healthcare professionals in the safe and effective administration of injectable medicines.

    £54.00Buy now
  • Print
  • Share
  • Comment
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.